Amgen Inc.
AMGN
$268.15
-$4.87-1.78%
Headlines
4/24/2024
-
Benzinga
4/24/2024
-
Ticker Report
4/24/2024
-
Zacks Investment Research
4/24/2024
-
Ticker Report
4/23/2024
-
Ticker Report
4/23/2024
-
Ticker Report
4/23/2024
-
Ticker Report
4/23/2024
-
Ticker Report
4/23/2024
-
24/7 Wall St.
4/22/2024
-
Ticker Report
4/22/2024
-
Zacks Investment Research
4/22/2024
-
Ticker Report
4/22/2024
-
Ticker Report
4/22/2024
-
Ticker Report
4/22/2024
-
Insider Monkey
4/22/2024
-
Stock Options Channel
4/22/2024
-
Zacks Investment Research
4/22/2024
-
Zolmax
4/22/2024
-
Zolmax
4/22/2024
-
Ticker Report
4/22/2024
-
Ticker Report
4/21/2024
-
Ticker Report
4/21/2024
-
Ticker Report
4/21/2024
-
Ticker Report
Filings
Wednesday, February 14, 2024
Sunday, December 31, 2023
Week of Apr 22 and 26 (est)
Price History
Corporate Info
805 447 1000
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
Thousand Oaks, CA 91320-1799
Business Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and...
more